Hercules Capital, Inc.

And if, say, if you're in a REIT and the consumer can't pay its rent, you're gonna see, like, a lot of credit risk in that regard.

Like, you could see a lot of defaults on the, on the leases, and you could see a lot of default from the companies, the BDC companies, and the financial companies that are loaning money out to s- to middle market companies for research and development, like a Hercules Capital or a Capital Southwest or a Trinity Capital for, for that matter.

Like, uh, those, so the BDCs and the financials could get h- uh, hit pretty hard as well.

So the things that pay the most money in the income stocks could see the most problems with the credit problem.

Who put the money in? And what's the growth story?

New investors Healthier Capital, Crosslink Capital, and Hercules Capital, alongside existing backers including Venrock and Flare Capital Partners.

Suki said revenue doubled in 2025, and patient encounters on its AI documentation tools grew more than one hundred and ninety percent year over year in 2026.

It didn't disclose evaluation.

The binding next steps are whether FDA accepts it and sets an action date.

On the supply side, upstream of the clinic, Northstar Medical Radioisotopes secured growth financing of up to $185 million, led by Hercules Capital, with $100 million funded at the start.

The money is for scaling Actinium-225 production and radiopharmaceutical manufacturing.

Actinium-225 supply is a real constraint on radiopharmaceutical development, so this capital is aimed at a bottleneck between those therapies and patients.

This is still private credit, so it needs monitoring.

Again, private credit like Hercules Capital is private credit.

Main Street Capital is private credit.

So private credit gets a bad rap when it comes to trading stocks because people just assume that the private credit market sucks.